Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB

Personal Subscription
Become EABM
Become Reviewer

Frequency Domain and Entropy Analysis of Fetal Heart Rate: Appealing Tools for Fetal Surveillance and Pharmacodynamic Assessment of Drugs

Volume:8   Issue: 2
Pp: 91-98
Hernani Goncalves, Ana Paula Rocha, Diogo Ayres-de-Campos and Joao Bernardes
DOI: 10.2174/187152908784533720

Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection

Volume:8   Issue: 2
Pp: 99-117
Archibald McNicol and Sara J. Israels
DOI: 10.2174/187152908784533739

Torasemide for the Treatment of Heart Failure

Volume:8   Issue: 2
Pp: 127-132
Hirotaka Ishido and Hideaki Senzaki
DOI: 10.2174/187152908784533685

Cardiovascular Effects of Ghrelin and Growth Hormone Secretagogues

Volume:8   Issue: 2
Pp: 133-137
Jorgen Isgaard, Anna Barlind and Inger Johansson
DOI: 10.2174/187152908784533676

The Role of Tirofiban in the Management of Coronary Artery Disease

Volume:8   Issue: 2
Pp: 138-146
Julian P. Winter and Craig P. Juergens
DOI: 10.2174/187152908784533748

Diabetic Heart and the Cardiovascular Surgeon

Volume:8   Issue: 2
Pp: 147-152
Chaim Yosefy
DOI: 10.2174/187152908784533694

Cardiac Role of the Transcription Factor NF-κB

Volume:8   Issue: 2
Pp: 153-160
Salomon Hernandez Gutierrez, Manuel Ramos Kuri and Emilio Rojas del Castillo
DOI: 10.2174/187152908784533702